✦ LIBER ✦

Efficacy of rituximab versus cyclophosphamide in lupus patients with severe manifestations. A randomized and multicenter study

✍ Scribed by Lilia Andrade-Ortega; Fedra Irazoque-Palazuelos; Ricardo López-Villanueva; Yaneth Barragán-Navarro; Fernando Bourget-Pietrasanta; Maria de los Ángeles Díaz-Ceballos; Roberto Hernández-Paz; Adelfia Urenda-Quezada; Rodolfo Rivas-Ruiz

Book ID: 119648593
Publisher: Elsevier Science
Year: 2010
Tongue: Spanish
Weight: 247 KB
Volume: 6
Category: Article
ISSN: 2173-5743
DOI: 10.1016/s2173-5743(10)70058-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of rituximab in pati

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study

✍ Brad H. Rovin; Richard Furie; Kevin Latinis; R. John Looney; Fernando C. Fervenz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Safety of remission induction with ritux

Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis

✍ Miloslavsky, E.; Specks, U.; Merkel, P.; Seo, P.; Spiera, R.; Langford, C.; Hoff 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 86 KB

A randomized multicenter trial of cyclop

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

✍ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-

Efficacy and safety of rosuvastatin alon

Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: A randomized, open-label, multicenter trial

✍ Christie M Ballantyne; Elinor Miller; Rohini Chitra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 752 KB

Efficacy and safety of doripenem versus

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

✍ Réa-Neto, Álvaro; Niederman, Michael; Margareth Lobo, Suzana; Schroeder, Eric; L 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 407 KB

Efficacy and safety of rituximab in adul

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study

✍ Javier de la Rubia; Federico Moscardó; María J Gómez; Ramón Guardia; Pilar Rodrí 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB